SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-161701
Filing Date
2024-06-14
Accepted
2024-06-14 17:01:07
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d851681ds3.htm S-3 208112
2 EX-5.1 d851681dex51.htm EX-5.1 5615
3 EX-23.1 d851681dex231.htm EX-23.1 1630
4 EX-FILING FEES d851681dexfilingfees.htm EX-FILING FEES 15117
5 GRAPHIC g851681g0612085003011.jpg GRAPHIC 4100
6 GRAPHIC g851681g08v07.jpg GRAPHIC 11778
7 GRAPHIC g851681g17k12.jpg GRAPHIC 69855
  Complete submission text file 0001193125-24-161701.txt   350022
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280235 | Film No.: 241045775
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)